• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25REC
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/22/2018
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that at the end cardiopulmonary bypass, a clot was noticed on the walls of the venous reservoir, when filling the patient with volume.The patient was still at 19 degrees when the reservoir was clamped and changed out.There was a delay of less than one minute for change out.The act was 569 just prior to cpb and that few thousand more of heparin was given before full cpb.There was no blood loss since the extra volume that was given was able to be hemoconcentrated prior to change out.No known impact or consequence to patient.Product was changed out.Procedure was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on july 11, 2018.(b)(4).The actual sample was not returned for evaluation; therefore a definitive root cause could not be determined.A retention sample from the same product code and lot number combination was performance tested no anomalies found.Visual inspection was also conducted prior to the test, and no anomalies were noted.The root cause could not be determined in the investigation.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25REC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key7678563
MDR Text Key113757018
Report Number1124841-2018-00136
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450820
UDI-Public(01)00699753450820
Combination Product (y/n)N
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2020
Device Model Number3CX*FX25REC
Device Catalogue NumberN/A
Device Lot NumberWA29
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 06/22/2018
Initial Date FDA Received07/11/2018
Supplement Dates Manufacturer Received09/06/2018
Supplement Dates FDA Received09/07/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-